Health and Healthcare

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1320 Articles

Chris Lange | Jun 8, 2015 at 1:00 PM EDT

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical…

Lee Jackson | Jun 6, 2015 at 9:15 AM EDT

Insider Buying Still Strong as Market Volatility Spikes

The jump in market volatility did not deter executives and 10% shareholders this week, and insider buying stayed solid.

Jon C. Ogg | Jun 2, 2015 at 10:45 AM EDT

5 Stocks That Warren Buffett Should Sell — or Add to the Stake

It turns out that Buffett has five public stocks that used to be far larger stakes or which seem like…

Paul Ausick | May 22, 2015 at 4:01 PM EDT

The 4 Stocks That Sank the DJIA on Friday

thinkstockMay 22 2015: Markets opened mixed on Friday on a day that was tough on blue chips. The energy sector…

Jon C. Ogg | May 21, 2015 at 8:05 AM EDT

10 Companies to Own for the Next Decade

Back in November of 2010, 24/7 Wall St. first issued a list of stocks to own for the next decade.…

Chris Lange | May 20, 2015 at 9:55 AM EDT

Can Another 10 Blockbuster Drugs Really Come From Johnson & Johnson in 5 Years?

Johnson & Johnson has been working on its pharmaceuticals pipeline for a while, and plans on continuing to do so.

Paul Ausick | May 18, 2015 at 4:01 PM EDT

The 4 Stocks That Lifted the DJIA on Monday

thinkstockMay 18, 2015: Markets opened lower on Monday, but the financial and healthcare sectors led the indexes above the break-even…

Jon C. Ogg | May 14, 2015 at 1:00 PM EDT

Key Dalio and Bridgewater Position Changes: Alcoa, Apple, CenturyLink, Cisco, Gilead, Emerging Markets

It turns out that hedge fund Bridgewater Associates and founder Ray Dalio have made some changes since the end of…

Lee Jackson | May 14, 2015 at 10:25 AM EDT

UBS Adds Oil Field Services Giant to Dividend Ruler Stocks Portfolio

UBS has added one of the world's largest oilfield services companies to its Dividend Ruler portfolio. Top dividend stocks continue…

Mike Sauter | May 6, 2015 at 2:43 PM EDT

Companies With the Best (and Worst) Reputations

Goldman Sachs has the worst reputation of any major American company. Upstate New York-based grocery chain Wegmans is the most…

Chris Lange | May 5, 2015 at 10:50 AM EDT

Top Credit Suisse Major Pharma Stock Picks to Buy

Credit Suisse has released a report that detailed its top picks for pharmaceutical stocks for the rest of 2015.

Chris Lange | Apr 25, 2015 at 9:05 AM EDT

4 Dividends and Buybacks That Should Not Be Ignored

24/7 Wall St. has collected and compiled dividend and buyback announcements within the past week that should not be ignored…

Paul Ausick | Apr 24, 2015 at 4:01 PM EDT

The 4 Stocks That Dominated the DJIA on Friday

thinkstockApril 24, 2015: Markets opened higher on Friday but only the Nasdaq Composite was able to hold onto its opening…

Jon C. Ogg | Apr 23, 2015 at 11:55 AM EDT

After Dividend Hike at J&J, Investors Can Expect Many Years of More Hikes

Johnson & Johnson is at it again. The consumer products and health care products giant has raised its common stock…

Paul Ausick | Apr 16, 2015 at 4:01 PM EDT

The 4 Stocks That Weighed on the DJIA Thursday

thinkstockApril 16, 2015: Markets opened lower on Thursday before climbing above the break-even line in the mid-afternoon. Crude oil futures…

1 … 51 52 53 54 55 … 89

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

Insider Buying Still Strong as Market Volatility Spikes

5 Stocks That Warren Buffett Should Sell — or Add to the Stake

The 4 Stocks That Sank the DJIA on Friday

10 Companies to Own for the Next Decade

Can Another 10 Blockbuster Drugs Really Come From Johnson & Johnson in 5 Years?

The 4 Stocks That Lifted the DJIA on Monday

Key Dalio and Bridgewater Position Changes: Alcoa, Apple, CenturyLink, Cisco, Gilead, Emerging Markets

UBS Adds Oil Field Services Giant to Dividend Ruler Stocks Portfolio

Companies With the Best (and Worst) Reputations

Top Credit Suisse Major Pharma Stock Picks to Buy

4 Dividends and Buybacks That Should Not Be Ignored

The 4 Stocks That Dominated the DJIA on Friday

After Dividend Hike at J&J, Investors Can Expect Many Years of More Hikes

The 4 Stocks That Weighed on the DJIA Thursday

Bank of America Says the Fed Should Raise Rates Now: 4 Dividend Inflation-Resistant Stocks

Price Prediction: Two Magnificent Seven Stocks, Two Bold Price Targets for 2027

3 AI Stocks Flying Under the Radar to Buy Before July Ends

Playing up the irony (small gig, real cost): "He Took a $20,000 Consulting Gig at 70. It Cost Him $1,148 in Medicare Premiums He Never Saw Coming.

A Tiny Home Looks Like Freedom on a Social Security Check. The Hidden Bills Say Otherwise.

Bank of America Says the Fed Should Raise Rates Now: 4 Dividend Inflation-Resistant Stocks

Price Prediction: Two Magnificent Seven Stocks, Two Bold Price Targets for 2027

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

Insider Buying Still Strong as Market Volatility Spikes

5 Stocks That Warren Buffett Should Sell — or Add to the Stake

The 4 Stocks That Sank the DJIA on Friday

10 Companies to Own for the Next Decade

Can Another 10 Blockbuster Drugs Really Come From Johnson & Johnson in 5 Years?

The 4 Stocks That Lifted the DJIA on Monday

Key Dalio and Bridgewater Position Changes: Alcoa, Apple, CenturyLink, Cisco, Gilead, Emerging Markets

UBS Adds Oil Field Services Giant to Dividend Ruler Stocks Portfolio

Companies With the Best (and Worst) Reputations

Top Credit Suisse Major Pharma Stock Picks to Buy

4 Dividends and Buybacks That Should Not Be Ignored

The 4 Stocks That Dominated the DJIA on Friday

After Dividend Hike at J&J, Investors Can Expect Many Years of More Hikes

The 4 Stocks That Weighed on the DJIA Thursday

Bank of America Says the Fed Should Raise Rates Now: 4 Dividend Inflation-Resistant Stocks

Price Prediction: Two Magnificent Seven Stocks, Two Bold Price Targets for 2027

3 AI Stocks Flying Under the Radar to Buy Before July Ends

Featured Reads

Playing up the irony (small gig, real cost): "He Took a $20,000 Consulting Gig at 70. It Cost Him $1,148 in Medicare Premiums He Never Saw Coming.

A Tiny Home Looks Like Freedom on a Social Security Check. The Hidden Bills Say Otherwise.